Attorney advertisingBriefMass Torts
FDA classifies Cardinal Health infusion-kit correction as Class I recall
Responsible attorney: Lou Schwartz, Schwartz & Associates, PC, Atlanta, Georgia. intake@snalawyers.com
The FDA announced it has raised to Class I, its most serious recall category, Cardinal Health's correction of Presource procedure kits that contain BD Alaris pump infusion sets already subject to a separate recall. The agency says the affected infusion sets can cause unpredictable pump behavior, including under-infusion, over-infusion, or failure to infuse, risks the agency has described as most serious for neonates and children in hospital settings. Cardinal Health has instructed hospital customers to quarantine the kits and remove and discard the recalled infusion sets before continued use. As of mid-August 2026, no serious injuries or deaths had been reported in connection with the issue, according to the FDA.
Why it matters. A Class I designation covering widely used hospital infusion kits, with heightened risk to neonatal and pediatric patients, can generate product-liability and wrongful-death inquiries that plaintiff firms track alongside other FDA device recalls.
Sources
- FDA recall notice
- ad-hoc-news.de secondary
Briefs summarize public developments. Unless stated otherwise, the firm is not counsel in the matters described, and allegations are not findings.
General information, not legal advice. Reading this article or using the intake assistant does not create an attorney-client relationship.